This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Podcast
The Challenges of Managing Bone Loss: Separating Fact from Fiction - Frankly Speaking EP 128Guest: Susan Feeney, DNP, FNP
Music Credit: Richard Onorato
Conflicting evidence-based guidelines and medication risks have complicated the care of individuals with low bone density. The Endocrine Society just released its most recent recommendations for pharmacologic management of postmenopausal women with osteoporosis. Their goal was to address the most challenging aspects of low bone density management with clear evidence-based guidance. Join us as we review their new recommendations, compare them with other guidelines, and discuss their impact on your practice.
Begin
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 7/2/2019
Expiration Date: 12/31/2021
Topics
Learning Objectives
- Identify the recent updates to The Endocrine Society’s evidence-based guidelines for pharmacologic treatment of osteoporosis in post-menopausal women
- Compare evidence-based guidelinesfrom the Endocrine Society and ACP pertaining to osteoporosis management
- Identify harm prevention strategies for patients at risk for bone loss, patients with low bone density and patients who are diagnosed with osteoporosis
Faculty Disclosures
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable